journal article·2021-07-28

RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2

Zhongqian Yang, Liangqun Hua, Mengli Yang, Shu-Qun Liu, Jianxin Shen, Weiran Li, Qiong Long, Hongmei Bai, Xu Yang, Zhaoling Ren, Xiao Zheng, Wenjia Sun, Chao Ye, Duo Li, Peng Zheng, Jinrong He, Yongjun Chen, Weiwei Huang, Xiaozhong Peng, Yanbing Ma

Nano Letters· Volume 21· Issue 14
Publisher page

Abstract

The disease caused by SARS-CoV-2 infection threatens human health. In this study, we used high-pressure homogenization technology not only to efficiently drive the bacterial membrane to produce artificial vesicles but also to force the fusion protein ClyA-receptor binding domain (RBD) to pass through gaps in the bacterial membrane to increase the contact between ClyA-RBD and the membrane. Therefore, the load of ClyA-RBD on the membrane is substantially increased. Using this technology, we constructed a "ring-like" bacterial biomimetic vesicle (BBV) loaded with polymerized RBD (RBD-BBV). RBD-BBVs injected subcutaneously can accumulate in lymph nodes, promote antigen uptake and processing, and elicit SARS-CoV-2-specific humoral and cellular immune responses in mice. In conclusion, we evaluated the potential of this novel bacterial vesicle as a vaccine delivery system and provided a new idea for the development of SARS-CoV-2 vaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: SARS-CoV-2 and COVID-19 Research · Bacterial Infections and Vaccines · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China

Yunnan University, Kunming, China

National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China

State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan & School of Life Sciences, Yunnan University, Kunming, China

The Second Affiliated Hospital of Kunming Medical University, Kunming, China

Kunming Medical University, Kunming, China

Department of Acute Infectious Diseases Control and Prevention, Yunnan Provincial Center for Disease Control and Prevention, Kunming, China

State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Medical Primate Research Center, Neuroscience Center, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China

Funding

National Natural Science Foundation of China · CAMS Initiative for Innovative Medicine · Fundamental Research Funds for the Central Universities and PUMC Youth Fund · Yunnan High-level Health and Technical Personnel Project · Science and Technology Project of Yunnan Province

References (46)

Show source-provided references
1. 10.1038/s41586-020-2180-510.1038/s41586-020-2180-5 ↗
2. 10.1038/s41586-020-2380-z10.1038/s41586-020-2380-z ↗
3. 10.1016/j.cell.2020.02.05810.1016/j.cell.2020.02.058 ↗
4. 10.1016/j.cell.2020.10.04310.1016/j.cell.2020.10.043 ↗
5. 10.1016/j.cell.2020.06.03510.1016/j.cell.2020.06.035 ↗
6. 10.1038/nmeth111610.1038/nmeth1116 ↗
7. 10.1038/nbt102910.1038/nbt1029 ↗
8. 10.1073/pnas.171834111510.1073/pnas.1718341115 ↗
9. 10.1073/pnas.151831111310.1073/pnas.1518311113 ↗
10. 10.3402/jev.v3.2401510.3402/jev.v3.24015 ↗
11. 10.1021/acs.nanolett.7b0389310.1021/acs.nanolett.7b03893 ↗
12. 10.1002/adma.20190818510.1002/adma.201908185 ↗
13. 10.1021/acsnano.0c0377610.1021/acsnano.0c03776 ↗
14. 10.1038/nature0802610.1038/nature08026 ↗
15. 10.1016/S0092-8674(03)00754-210.1016/S0092-8674(03)00754-2 ↗
16. 10.1038/ncomms719810.1038/ncomms7198 ↗
17. 10.1002/advs.20170008310.1002/advs.201700083 ↗
18. 10.1021/acsami.0c1552210.1021/acsami.0c15522 ↗
19. 10.1002/adfm.20190143710.1002/adfm.201901437 ↗
20. 10.2147/IJN.S24353710.2147/IJN.S243537 ↗
21. 10.1006/cimm.2001.188310.1006/cimm.2001.1883 ↗
22. 10.1021/nl504798g10.1021/nl504798g ↗
23. 10.1016/j.actbio.2019.04.03310.1016/j.actbio.2019.04.033 ↗
24. 10.1002/adma.20200421010.1002/adma.202004210 ↗
25. 10.1021/acs.accounts.0c0033610.1021/acs.accounts.0c00336 ↗
26. 10.1016/j.immuni.2020.12.00910.1016/j.immuni.2020.12.009 ↗
27. 10.7554/eLife.6350210.7554/eLife.63502 ↗
28. 10.1146/annurev-immunol-030409-10121210.1146/annurev-immunol-030409-101212 ↗
29. 10.1126/science.278.5342.144710.1126/science.278.5342.1447 ↗
30. 10.1038/nm.244710.1038/nm.2447 ↗
31. 10.1073/pnas.160310611310.1073/pnas.1603106113 ↗
32. 10.1073/pnas.180620011510.1073/pnas.1806200115 ↗
33. 10.1016/j.cell.2020.11.02910.1016/j.cell.2020.11.029 ↗
34. 10.1021/acsnano.9b0032610.1021/acsnano.9b00326 ↗
35. 10.3390/vaccines903024010.3390/vaccines9030240 ↗
36. 10.1038/s41586-020-2599-810.1038/s41586-020-2599-8 ↗
37. 10.1038/s41467-020-16639-110.1038/s41467-020-16639-1 ↗
38. 10.1056/NEJMoa140601110.1056/NEJMoa1406011 ↗
39. 10.1016/j.ymthe.2017.01.01010.1016/j.ymthe.2017.01.010 ↗
40. 10.3390/vaccines702004610.3390/vaccines7020046 ↗
41. 10.1126/sciadv.aba273510.1126/sciadv.aba2735 ↗
42. 10.1002/adma.20200208510.1002/adma.202002085 ↗
43. 10.1038/s41467-017-00729-810.1038/s41467-017-00729-8 ↗
44. 10.1016/j.jconrel.2019.11.01710.1016/j.jconrel.2019.11.017 ↗
45. 10.1021/nn405724x10.1021/nn405724x ↗
46. 10.1038/s41467-019-09034-y10.1038/s41467-019-09034-y ↗